BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q2 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/08/2024- NAV $55.03
- NAV Change $-0.63
- Market Price $54.96
- Market Price Change $-0.65
- Trading Volume (M) 10,286
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/08/2024- NAV $55.03
- NAV Change $-0.63
- Market Price $54.96
- Market Price Change $-0.65
- Trading Volume (M) 10,286
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 3/28/2024
Holdings
as of 5/08/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
47.54% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 42,519,877 | -- | 9,764 | -- |
36.15% | -- | NASDAQ BIO INDEX SWAP BNP | 32,334,093 | -- | 7,425 | -- |
18.95% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 16,953,081 | -- | 3,893 | -- |
12.79% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 11,435,600 | -- | 2,626 | -- |
6.45% | AMGN | AMGEN INC | -- | $5,772,818.35 | 18,785 | 2023607 |
6.43% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,752,638 | -- | 1,321 | -- |
5.72% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $5,120,493.32 | 12,226 | 2931034 |
5.69% | REGN | REGENERON PHARMACEUTICALS | -- | $5,090,377.76 | 5,326 | 2730190 |
5.18% | GILD | GILEAD SCIENCES INC | -- | $4,631,587.56 | 71,343 | 2369174 |
5.07% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,537,660 | -- | 1,042 | -- |
3.42% | MRNA | MODERNA INC | -- | $3,058,341.99 | 25,091 | BGSXTS3 |
3.33% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 2,974,301 | -- | 683 | -- |
3.29% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,943,101.89 | 38,237 | 2989044 |
2.34% | BIIB | BIOGEN INC | -- | $2,097,227.40 | 9,545 | 2455965 |
1.41% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,259,742.88 | 8,272 | B00FWN1 |
1.29% | ILMN | ILLUMINA INC | -- | $1,154,098.46 | 10,433 | 2613990 |
1.13% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $1,013,628.21 | 12,387 | 2437071 |
1.03% | VTRS | VIATRIS INC | -- | $920,943.80 | 77,980 | BMWS3X9 |
1.02% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $908,773.74 | 6,537 | 2623911 |
1.01% | SNY | SANOFI-ADR | -- | $901,198.80 | 17,988 | 2964557 |
0.92% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $821,058.66 | 29,334 | BMVP7Y0 |
0.91% | SRPT | SAREPTA THERAPEUTICS INC | -- | $817,223.12 | 6,164 | B8DPDT7 |
0.90% | UTHR | UNITED THERAPEUTICS CORP | -- | $807,290.28 | 3,092 | 2430412 |
0.88% | INCY | INCYTE CORP | -- | $789,058.46 | 14,746 | 2471950 |
0.88% | ARGX | ARGENX SE - ADR | -- | $788,761.44 | 2,043 | BDVLM39 |
0.88% | MEDP | MEDPACE HOLDINGS INC | -- | $783,359.81 | 2,021 | BDCBC61 |
0.66% | ROIV | ROIVANT SCIENCES LTD | -- | $593,188.36 | 52,916 | BMW4NZ9 |
0.64% | BNTX | BIONTECH SE-ADR | -- | $572,866.28 | 6,356 | BK6H543 |
0.56% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $505,317.89 | 3,773 | BV9G6B8 |
0.53% | PCVX | VAXCYTE INC | -- | $475,277.64 | 7,116 | BKPVGH6 |
0.51% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $452,984.40 | 4,092 | B4Q5ZN4 |
0.50% | BGNE | BEIGENE LTD-ADR | -- | $447,112.36 | 2,719 | BYYWPW6 |
0.49% | CYTK | CYTOKINETICS INC | -- | $441,290.47 | 6,761 | BBBSBJ5 |
0.49% | BPMC | BLUEPRINT MEDICINES CORP | -- | $437,513.16 | 4,022 | BWY52P3 |
0.48% | EXEL | EXELIXIS INC | -- | $429,878.49 | 19,911 | 2576941 |
0.48% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $426,120.00 | 6,360 | BHCB0P4 |
0.46% | RVMD | REVOLUTION MEDICINES INC | -- | $414,399.27 | 10,817 | BL71K91 |
0.43% | IONS | IONIS PHARMACEUTICALS INC | -- | $384,491.84 | 9,574 | BDJ0LS6 |
0.39% | HALO | HALOZYME THERAPEUTICS INC | -- | $349,775.26 | 8,326 | 2975098 |
0.39% | IBRX | IMMUNITYBIO INC | -- | $347,236.56 | 43,843 | BNSP0B8 |
0.37% | APLS | APELLIS PHARMACEUTICALS INC | -- | $335,058.30 | 7,921 | BYTQ6X1 |
0.36% | BBIO | BRIDGEBIO PHARMA INC | -- | $319,796.50 | 11,545 | BK1KWG8 |
0.33% | KRYS | KRYSTAL BIOTECH INC | -- | $292,654.08 | 1,856 | BD6JX35 |
0.32% | IMVT | IMMUNOVANT INC | -- | $283,910.40 | 9,540 | BJRFSB7 |
0.31% | CRSP | CRISPR THERAPEUTICS AG | -- | $280,944.88 | 5,272 | BDHF4K6 |
0.31% | ALPN | ALPINE IMMUNE SCIENCES INC | -- | $278,598.20 | 4,306 | BYX38M1 |
0.30% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $272,116.32 | 1,308 | BD59BS7 |
0.30% | ALKS | ALKERMES PLC | -- | $264,377.00 | 10,970 | B3P6D26 |
0.29% | NUVL | NUVALENT INC-A | -- | $260,164.08 | 3,852 | BMVBZD3 |
0.28% | INSM | INSMED INC | -- | $253,448.00 | 9,748 | 2614487 |
0.27% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $245,585.99 | 18,341 | BF0DMK7 |
0.27% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $239,298.48 | 5,234 | BMX9K07 |
0.26% | AXSM | AXSOME THERAPEUTICS INC | -- | $235,289.12 | 3,109 | BYZR4X4 |
0.26% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $232,719.97 | 4,573 | BDD19F8 |
0.26% | SMMT | SUMMIT THERAPEUTICS INC | -- | $228,536.96 | 46,076 | BMTVQS7 |
0.25% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $224,756.48 | 5,408 | BJ62Z18 |
0.24% | XENE | XENON PHARMACEUTICALS INC | -- | $212,632.29 | 4,953 | BRJ3GY4 |
0.23% | FTRE | FORTREA HOLDINGS INC | -- | $206,929.50 | 5,829 | BRXYZ57 |
0.23% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $205,240.36 | 8,138 | BYQBFJ8 |
0.23% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $204,665.18 | 4,843 | BGMGM89 |
0.23% | IDYA | IDEAYA BIOSCIENCES INC | -- | $202,660.54 | 4,894 | BK0VHF6 |
0.22% | FOLD | AMICUS THERAPEUTICS INC | -- | $196,665.30 | 19,395 | B19FQ48 |
0.21% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $185,397.99 | 10,823 | 2713317 |
0.21% | JANX | JANUX THERAPEUTICS INC | -- | $184,160.62 | 3,326 | BMFX8Y7 |
0.20% | ACLX | ARCELLX INC | -- | $181,046.25 | 3,465 | BPCJ1Q2 |
0.20% | MRUS | MERUS NV | -- | $179,036.18 | 3,802 | BZBY005 |
0.19% | DNLI | DENALI THERAPEUTICS INC | -- | $172,689.30 | 9,137 | BD2B4V0 |
0.18% | TWST | TWIST BIOSCIENCE CORP | -- | $157,195.80 | 3,797 | BGKG6G7 |
0.18% | PTCT | PTC THERAPEUTICS INC | -- | $156,603.06 | 5,029 | B17VCN9 |
0.17% | VERA | VERA THERAPEUTICS INC | -- | $154,998.06 | 3,449 | BL55460 |
0.17% | KYMR | KYMERA THERAPEUTICS INC | -- | $154,500.50 | 4,013 | BMPRZV5 |
0.17% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $153,578.32 | 3,946 | BF2YWG4 |
0.17% | VCEL | VERICEL CORP | -- | $151,224.99 | 3,171 | BSBMN89 |
0.17% | GH | GUARDANT HEALTH INC | -- | $148,989.52 | 7,993 | BFXC911 |
0.16% | NTLA | INTELLIA THERAPEUTICS INC | -- | $145,199.00 | 6,313 | BYZM6C2 |
0.16% | ARVN | ARVINAS INC | -- | $144,758.64 | 4,472 | BDZ30Q0 |
0.16% | MYGN | MYRIAD GENETICS INC | -- | $141,376.85 | 5,903 | 2614153 |
0.16% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $138,767.16 | 2,263 | BLCD809 |
0.15% | KROS | KEROS THERAPEUTICS INC | -- | $137,621.12 | 2,363 | BM7V485 |
0.15% | SANA | SANA BIOTECHNOLOGY INC | -- | $137,396.22 | 14,478 | BMFJJ97 |
0.15% | DYN | DYNE THERAPEUTICS INC | -- | $136,876.32 | 5,328 | BN15WD1 |
0.15% | GERN | GERON CORP | -- | $136,607.55 | 35,855 | 2370381 |
0.15% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $136,593.12 | 5,944 | BDFKQ07 |
0.15% | RNA | AVIDITY BIOSCIENCES INC | -- | $136,476.22 | 5,237 | BMWHPY1 |
0.15% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $134,587.85 | 5,305 | BZ1LFB2 |
0.15% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $133,256.97 | 3,157 | BNFWZS4 |
0.14% | ARDX | ARDELYX INC | -- | $129,591.36 | 15,282 | BN89V40 |
0.14% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $128,137.03 | 14,917 | BM9FJ13 |
0.14% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $127,721.46 | 6,114 | BKY5JZ8 |
0.14% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $125,347.12 | 3,196 | BQS9486 |
0.14% | APGE | APOGEE THERAPEUTICS INC | -- | $125,074.40 | 2,440 | BM9HHL5 |
0.14% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $124,880.40 | 5,580 | BN7Q7R7 |
0.13% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $119,712.48 | 3,688 | BCBVTX1 |
0.13% | BEAM | BEAM THERAPEUTICS INC | -- | $119,273.12 | 5,363 | BK6L288 |
0.13% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $118,082.50 | 3,725 | BKSGZN7 |
0.13% | NVCR | NOVOCURE LTD | -- | $112,690.90 | 7,030 | BYSS4X4 |
0.13% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $112,398.30 | 3,591 | B72ZBG4 |
0.12% | INBX | INHIBRX INC | -- | $107,142.84 | 3,111 | BK1MBC3 |
0.12% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $103,695.75 | 3,825 | BDCBCD8 |
0.11% | ADMA | ADMA BIOLOGICS INC | -- | $102,797.10 | 14,985 | B9NSBM2 |
0.11% | KURA | KURA ONCOLOGY INC | -- | $102,725.00 | 5,000 | BYZD465 |
0.11% | FUSN | FUSION PHARMACEUTICALS INC | -- | $101,692.80 | 4,752 | BJK0NH0 |
0.11% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $99,933.70 | 8,578 | BRJZSK0 |
0.11% | VCYT | VERACYTE INC | -- | $99,231.84 | 4,932 | BFTWZY0 |
0.11% | MORF | MORPHIC HOLDING INC | -- | $96,319.72 | 3,284 | BK8M4J4 |
0.11% | -- | AVADEL PHARMACEUTICALS | -- | $95,761.25 | 5,893 | BDGMC59 |
0.11% | XNCR | XENCOR INC | -- | $94,947.58 | 4,013 | BGCYWN8 |
0.11% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $94,127.76 | 5,736 | BLB0YH0 |
0.10% | LGND | LIGAND PHARMACEUTICALS | -- | $93,458.68 | 1,163 | 2501578 |
0.10% | ANIP | ANI PHARMACEUTICALS INC | -- | $90,752.46 | 1,383 | BCDWBX6 |
0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $90,610.40 | 3,056 | B3X26D8 |
0.10% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $86,099.10 | 3,270 | BKLXFX5 |
0.09% | VIR | VIR BIOTECHNOLOGY INC | -- | $84,572.10 | 8,865 | BK4PZ38 |
0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $84,000.15 | 2,249 | BMH5RL1 |
0.09% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $83,481.72 | 10,281 | B3MZ6K5 |
0.09% | PRTA | PROTHENA CORP PLC | -- | $81,249.84 | 3,528 | B91XRN2 |
0.09% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $79,887.94 | 2,099 | BX7RSN3 |
0.09% | GMAB | GENMAB A/S -SP ADR | -- | $79,257.60 | 2,752 | BBC9WC7 |
0.09% | MNKD | MANNKIND CORP | -- | $78,130.80 | 17,757 | BF081J4 |
0.09% | CGEM | CULLINAN THERAPEUTICS INC | -- | $77,865.48 | 2,809 | BM90J52 |
0.09% | AKRO | AKERO THERAPEUTICS INC | -- | $77,689.92 | 3,696 | BK7Y2V9 |
0.09% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $77,044.82 | 8,686 | BMCWKZ2 |
0.09% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $76,597.36 | 3,059 | BJDX8Y8 |
0.08% | ABCL | ABCELLERA BIOLOGICS INC | -- | $73,824.00 | 19,225 | BL53SR3 |
0.08% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $69,048.90 | 13,539 | 2100362 |
0.08% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $68,701.00 | 4,738 | BFZQ0L8 |
0.07% | VRNA | VERONA PHARMA PLC - ADR | -- | $66,394.56 | 4,462 | BYWPZK5 |
0.07% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $66,220.96 | 2,704 | BMFD115 |
0.07% | INVA | INNOVIVA INC | -- | $64,605.12 | 4,152 | BDDXF67 |
0.07% | MGNX | MACROGENICS INC | -- | $59,739.50 | 4,075 | BFDV8K0 |
0.06% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $57,948.66 | 4,662 | BMQ5T49 |
0.06% | SPRY | ARS PHARMACEUTICALS INC | -- | $57,123.30 | 6,305 | BMCR7V2 |
0.06% | RLAY | RELAY THERAPEUTICS INC | -- | $56,077.14 | 8,614 | BN2R582 |
0.06% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $55,294.42 | 2,341 | BKDQKM6 |
0.06% | ETNB | 89BIO INC | -- | $55,272.63 | 6,121 | BK1K484 |
0.06% | GRFS | GRIFOLS SA-ADR | -- | $54,774.72 | 8,008 | B8K7T65 |
0.06% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $54,364.53 | 3,273 | BLN7XQ1 |
0.06% | ZLAB | ZAI LAB LTD-ADR | -- | $53,885.64 | 3,252 | BD9GVY0 |
0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $53,162.24 | 2,624 | BD0MGM0 |
0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $53,023.14 | 3,954 | BMDWW66 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $52,981.18 | 6,698 | BP2P6L0 |
0.06% | COGT | COGENT BIOSCIENCES INC | -- | $51,854.80 | 6,823 | BLR6XK8 |
0.06% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $50,816.40 | 6,360 | BKX9VD3 |
0.06% | EOLS | EVOLUS INC | -- | $49,764.78 | 3,753 | BDRJH21 |
0.05% | SAGE | SAGE THERAPEUTICS INC | -- | $48,940.50 | 3,950 | BP4GNK9 |
0.05% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $48,899.25 | 9,495 | BFWLC09 |
0.05% | RGNX | REGENXBIO INC | -- | $48,676.40 | 2,920 | BZ0G875 |
0.05% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $47,807.97 | 1,757 | BKC9SX3 |
0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $46,870.20 | 8,012 | BYZG9R0 |
0.05% | IRON | DISC MEDICINE INC | -- | $46,415.88 | 1,582 | BMGJZJ8 |
0.05% | ANAB | ANAPTYSBIO INC | -- | $44,959.50 | 1,746 | BDRW1L7 |
0.05% | NRIX | NURIX THERAPEUTICS INC | -- | $44,875.80 | 3,210 | BMVLGP2 |
0.05% | SVRA | SAVARA INC | -- | $44,351.12 | 8,888 | BYXGN81 |
0.05% | CSTL | CASTLE BIOSCIENCES INC | -- | $42,489.70 | 1,805 | BKLCWZ3 |
0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $42,470.40 | 4,424 | BKVDFF7 |
0.05% | CVAC | CUREVAC NV | -- | $42,338.88 | 14,701 | BN4RD42 |
0.05% | LYEL | LYELL IMMUNOPHARMA INC | -- | $41,712.50 | 16,685 | BN6MB18 |
0.05% | ZYME | ZYMEWORKS INC | -- | $41,648.82 | 4,597 | BPCQZY9 |
0.05% | OCUL | OCULAR THERAPEUTIX INC | -- | $41,624.25 | 7,239 | BNZB1X8 |
0.05% | NVAX | NOVAVAX INC | -- | $41,079.30 | 9,190 | BJDQXG4 |
0.05% | PRME | PRIME MEDICINE INC | -- | $41,030.80 | 7,655 | BPBJFM7 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $39,621.45 | 2,035 | BYXV9H7 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $39,584.30 | 2,702 | BP9N0G0 |
0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $39,255.30 | 3,618 | BMZ4LN0 |
0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $39,155.97 | 2,877 | BG31GH0 |
0.04% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $37,988.73 | 9,243 | BFMLGR4 |
0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $37,986.10 | 3,761 | BJLKVS6 |
0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $37,622.88 | 1,296 | B292NQ7 |
0.04% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $37,061.36 | 3,206 | BMGS7L1 |
0.04% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $35,094.96 | 3,702 | BLB0YQ9 |
0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $34,995.00 | 4,666 | 2107437 |
0.04% | OABI | OMNIAB INC | -- | $34,653.82 | 7,633 | BN13S71 |
0.04% | TVTX | TRAVERE THERAPEUTICS INC | -- | $34,079.54 | 4,997 | BLFGJD5 |
0.04% | CABA | CABALETTA BIO INC | -- | $33,993.12 | 2,814 | BK5MWR1 |
0.04% | PETQ | PETIQ INC | -- | $33,835.05 | 1,917 | BDH65C8 |
0.04% | VERV | VERVE THERAPEUTICS INC | -- | $33,385.28 | 5,491 | BNKGXX2 |
0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $32,935.86 | 2,731 | BD06CS0 |
0.04% | ALEC | ALECTOR INC | -- | $32,629.53 | 6,287 | BJ4LDC4 |
0.04% | MXCT | MAXCYTE INC | -- | $31,570.56 | 6,804 | BKMQF66 |
0.03% | THRD | THIRD HARMONIC BIO INC | -- | $31,278.87 | 2,653 | BNNPQY8 |
0.03% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $31,271.24 | 11,011 | BZ0QMB7 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $31,051.28 | 3,272 | BMNDK09 |
0.03% | FULC | FULCRUM THERAPEUTICS INC | -- | $30,876.12 | 4,068 | BJDX8Z9 |
0.03% | HUMA | HUMACYTE INC | -- | $30,686.04 | 6,804 | BMYTJP4 |
0.03% | SLRN | ACELYRIN INC | -- | $30,622.47 | 6,393 | BQPF874 |
0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $30,552.05 | 3,565 | BY7RB53 |
0.03% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $30,492.48 | 11,048 | BFZNYB7 |
0.03% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $30,289.50 | 9,525 | BJ5FZ74 |
0.03% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $29,562.96 | 17,597 | B4N8MH9 |
0.03% | TSHA | TAYSHA GENE THERAPIES INC | -- | $29,221.64 | 12,278 | BNC1BX1 |
0.03% | ITOS | ITEOS THERAPEUTICS INC | -- | $28,645.60 | 2,348 | BMWXFT4 |
0.03% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $28,364.25 | 16,025 | BWFZX59 |
0.03% | EDIT | EDITAS MEDICINE INC | -- | $27,063.13 | 5,375 | BZ8FPH3 |
0.03% | REPL | REPLIMUNE GROUP INC | -- | $26,940.44 | 4,033 | BDDVW37 |
0.03% | URGN | UROGEN PHARMA LTD | -- | $26,924.83 | 2,029 | BZ7PJQ1 |
0.03% | TRML | TOURMALINE BIO INC | -- | $26,155.10 | 1,682 | BQ80NC6 |
0.03% | BMEA | BIOMEA FUSION INC | -- | $25,925.94 | 2,342 | BNKF6N0 |
0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $24,731.84 | 5,792 | BJFSR99 |
0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $24,544.85 | 4,057 | BMDJ0C9 |
0.03% | HROW | HARROW INC | -- | $23,777.28 | 2,304 | BHNDW86 |
0.03% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $22,935.30 | 1,335 | BL95N25 |
0.02% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $21,934.05 | 8,215 | BNG1NK8 |
0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $21,915.03 | 10,903 | BN6M8F1 |
0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $21,862.43 | 25,336 | 2301938 |
0.02% | PGEN | PRECIGEN INC | -- | $21,741.51 | 16,347 | BKM5C84 |
0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $21,717.18 | 5,526 | BLN9Z50 |
0.02% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $21,454.36 | 4,174 | BFYQFJ2 |
0.02% | ERAS | ERASCA INC | -- | $21,334.45 | 9,923 | BNLYBF3 |
0.02% | CRBU | CARIBOU BIOSCIENCES INC | -- | $20,328.00 | 5,808 | BNYJR68 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $20,239.36 | 3,776 | B12W3P6 |
0.02% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $20,000.61 | 5,391 | BYTYP72 |
0.02% | RAPT | RAPT THERAPEUTICS INC | -- | $18,002.88 | 2,256 | BK5T6R0 |
0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $17,280.48 | 3,892 | BMG99Y1 |
0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $16,783.20 | 9,072 | BLR7H87 |
0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $16,305.76 | 7,312 | BRK0149 |
0.02% | QURE | UNIQURE NV | -- | $15,374.16 | 3,144 | BJFSR88 |
0.02% | ACIU | AC IMMUNE SA | -- | $15,251.50 | 6,490 | BZC0D70 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $14,826.24 | 3,168 | BP48134 |
0.02% | OVID | OVID THERAPEUTICS INC | -- | $14,340.69 | 4,641 | BYPFK63 |
0.01% | BLUE | BLUEBIRD BIO INC | -- | $12,183.47 | 12,501 | BBFL7S1 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $9,999.13 | 20,715 | BM9CKX3 |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $8,586.57 | 4,449 | BPCK358 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $5,685.20 | 4,660 | BYV2W40 |
0.01% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $5,126.55 | 3,585 | BM8MVZ3 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $4,004.04 | 2,188 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,801,506.20 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $12,251,238.65 | 12,251,239 | -- |
Index
as of 3/28/2024
- Total Number of Companies218
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$6.77 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|